Evidence map›Paper›PMID 32341411›Full record

ArticleScientific reports2020

Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomics.

Frank Vrieling, Sarantos Kostidis, Herman P Spaink, Mariëlle C Haks, Oleg A Mayboroda, Tom H M Ottenhoff, Simone A Joosten

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
0.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Model systems to studyFrontiers in cellular and infection microbiology · 2025
    Review
  13. Article
  14. Article
  15. The Human PathogenBiology · 2024
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Frank VrielingDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Sarantos KostidisCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Herman P SpainkInstitute of Biology, Leiden University, Leiden, The Netherlands.
Mariëlle C HaksDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Oleg A MayborodaCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Tom H M OttenhoffDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Simone A JoostenDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands. S.A.Joosten@LUMC.nl.
Leiden University Medical Center · NLLeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenic success of Mycobacterium tuberculosis (Mtb) is tightly linked to its ability to recalibrate host metabolic processes in infected host macrophages. Since changes in cellular metabolic intermediates or pathways also affect macrophage function in response to pathogens, we sought to analyse specific metabolic alterations induced by Mtb infection. Stimulation of macrophages with Mtb lysate or lipopolysaccharide (LPS) induced a relative increase in glycolysis versus oxidative phosphorylation. Cellular metabolomics revealed that Mtb infection induced a distinct metabolic profile compared to LPS in both M1 and M2 macrophages. Specifically, Mtb infection resulted in elevated intracellular levels of nicotinamide adenine dinucleotide (NAD

Indexed as

CreatineGlucoseGlutamineHumansLipopolysaccharidesMacrophagesMycobacterium tuberculosisTuberculosisCreatineGlucoseGlutamineLipopolysaccharides

Identifiers

PMID32341411
PMCPMC7184630
OpenAlexW3019725052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.